Estrogen receptor expression in tumors different from breast cancer

Antibiotiki i Khimioterapiya

Volumn 54, Issue 7-8, 2009, Pages 41-49

  Bogush, T A ^a   Dudko', E A ^a   Beme, A A ^a   Bogush, E A ^a   Polotsky, B E ^a   Tjuuandin, S A ^a   Davydov, M I ^a  

^a NONE

Author keywords

Estrogen receptors; Solid human tumors; Tamoxifen

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN; TUMOR MARKER;

ADJUVANT CHEMOTHERAPY; BREAST TUMOR; FEMALE; HUMAN; MALE; METABOLISM; NEOPLASM; PROGNOSIS; REVIEW;

BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; MALE; NEOPLASMS; PROGNOSIS; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN; TUMOR MARKERS, BIOLOGICAL;

EID: 77649152849     PISSN: 02352990     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (121)

1. ALI G., Donati V., Loggini B. et al. Different estrogen receptor beta expression in distinct histologic subtypes of lung adenocarcinoma. Hum Pathol 2008; 39: 10: 1465-1473.
2. Skov B. G., Fischer B. M., Pappot H. Oestrogen receptor beta over expression in males with non-small cell lung cancer is associated with better survival. Lung Cancer 2008; 59:1: 88-94.
3. Schwartz A. G., Prysak G. M., Murphy V. et al. Nuclear estrogen receptor beta in lung cancer: expression and survival differences by sex. Clin Cancer Res 2005; 11: 20: 7280-7287. (Pubitemid 41507685)
4. Wu C. T., Chang Y. L., Shih J. Y., Lee Y. C. The significance of estrogen receptor beta in 301 surgically treated non-small cell lung cancers. J. Thorac Cardiovasc Surg 2005; 130: 4: 979-986.
5. Kawai H., Ishii A., Washiya K. et al. Estrogen receptors alpha and beta are prognostic factors in non-small cell lung cancer. Clin Cancer Res 2005; 11: 14: 5084-5089. (Pubitemid 41003691)
6. Fosco M. J., Hurteau G. J., Spivack S. D. Gender-dependent expression of alpha and beta estrogen receptors in human nontumor and tumor lung tissue. Mol Cell Endocrinol 2002; 188: 1-2: 125-140.
7. Dabbs D. J., Landreneau R. J., Liu Y. et al. Detection of estrogen receptor by immunohistochemistry in pulmonary adenocarcinoma. Ann Thorac Surg 2002; 73: 2: 403-406. (Pubitemid 34117378)
8. Yang M. H. Estrogen receptor in female lung carcinoma. Zhonghua Jie He He Hu Xi Za Zhi 1992; 15: 3: 138-140, 189.
9. Beattie C. W., Hansen N. W., Thomas P. A. Steroid receptors in human lung cancer. Cancer Res 1985; 45: 9: 4206-4214.
10. TraynorA. M., Schiller J. H., Stabile L. P. et al. Pilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancer. Lung Cancer 2009; 64: 1: 51-59.
11. Radzikowska E., Langfort R., Giedronowicz D. Estrogen and progesterone receptors in non small cell lung cancer patients. Ann Thorac. Cardiovasc Surg 2002; 8 (2): 69-73.
12. Cagle P. T., Mody D. R., Schwartz M. R. Estrogen and progesterone receptors in bronchogenic carcinoma. Cancer Res 1990; 50: 20: 6632-6635.
13. Lau S. K, Chu P. G, Weiss L. M. Immunohistochemical expression of estrogen receptor in pulmonary adenocarcinoma. Appl Immunohistochem Mol. Morphol 2006; 14: 1: 83-87.
14. DiNunnoL.,LarssonL.G.,RinehartJ.J.,BeissnerR.S. Estrogenandprogesteronereceptorsinnon- smallcelliungcancerin248consecutivepatientswhounderwentsurgicalresection. ArchPatholLabMed2000;124:10:1467-1470.(Pubitemid30802495)
15. Su J.M.,HsuH.K,ChangH.etal. Expressionofestrogenandprogesteronereceptorsinnon-small- celllungcancerimmunohistochemicalstudy.AnticancerRes1996;16:6B:3803-3806. (Pubitemid27085052)
16. Zhang G., Liu X., Parkas A. M. et al. Estrogen receptor beta functions through nongenomic mechanisms in lung cancer cells. Mol. Endocrinol 2009; 23: 2: 146-156.
17. Márquez-Garbán D. C., Chen H. W., Fishbein M. C. et al. Estrogen receptor signalling pathways in human non-small cell lung cancer. Steroids 2007; 72: 2: 135-143. (Pubitemid 46273500)
18. Pietras R. J., Márquez D. C., Chen H. W. et al. Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells. Ibid 2005; 70: 5-7: 372-381. (Pubitemid 40616035)
19. Wu C. T., Chang Y. L., Lee Y. C. Expression of the estrogen receptor beta in 37 surgically treated pulmonary sclerosing hemangiomas in comparison with non-small cell hing carcinomas. Hum Pathol 2005; 36: 10: 1108-1112.
20. Dougherty S. M., Mazhawidza W., Bohn A R. et al. Gender difference in the activity but not expression of estrogen receptors alpha and beta in human lung adenocarcinoma cells. Endocr Relat Cancer 2006; 13: 1: 113-134.
21. Sica G., Wagner P. L., Altorki N. et al. Immunohistochemical expression of estrogen and progesterone receptors in primary pulmonary neuroendocrine tumors. Arch Pathol Lab Med 2008; 132: 12: 1889-1895.
22. Wang L. Y. Estrogen and progesterone receptors in esophageal carcinoma cells. Zhonghua Zhong Liu Za Zhi 1991; 13: 1: 23-25.
23. Nozoe T., Oyama T., Takenoyama M. et al. Significance of immunohistochemical expression of estrogen receptors alpha and beta in squamous cell carcinoma of the esophagus. Clin Cancer Res 2007; 13: 14: 4046-4050.
24. LiuL.,ChirolaM.,YounesM.Expressionofestrogenreceptor- betaisoformsinBarrett'smetaplasia,dysplasiaandesophagealadenocarcinoma. AnticancerRes2004;24:5A:2919-2924.(Pubitemid39407167)
25. AkgunH,LechagoJ.,YounesM.Estrogenreceptor- betaisexpressedinBarrett'smetaplasiaandassociatedadenocarcinomaoftheesophagus. Ibid2002;22:3:1459-1461.(Pubitemid34839150)
26. Kalayarasan R., Ananthakrtshnan N., Kate V., Basu D. Estrogen and progesterone receptors in esophageal carcinoma. Dis. Esophagus 2008; 21: 4: 298-303. (Pubitemid 351663444)
27. García- Velasco A., Mendiola C., Sánchez-Muñoz A. et al. Prognostic value of hormonal receptors, p53, ki67 and HER2/neu expression in epithelial ovarian carcinoma. Clin Transi Oncol 2008; 10: 6: 367-371.
28. De Sousa Damião R, Fujiyama Oshima C. T., Stávale J. N., Gonçalves W. J. Analysis of the expression of estrogen receptor, progesterone receptor and chicken ovalbumin upstream promoter-transcription factor I in ovarian epithelial cancers and normal ovaries. Oncol Rep 2007; 18:1:25-32.
29. Han L. P., Dong Z. M., Qiao Y. H. et al. Expressions of estrogen receptor subtypes in epithelial ovarian carcinomas. Sichuan Da Xue Xue Bao Yi Xue Ban 2006; 37:4:606-610.
30. PujolP.,ReyJ.M.,NirdeP.etal.Differentialexpressionofestrogenreceptor- alphaand-betamessengerRNAsasapotentialmarkerofovariancarcinogenesis. CancerRes1998;58:23:5367-5373.(Pubitemid28551118)
31. Fischer-ColbrieJ.,WittA.,HeinzlH.etal. EGFRandsteroidreceptorsinovariancarcinoma: comparisonwithprognosticparametersandoutcomeofpatients.AnticancerRes1997;17:1B: 613-619.(Pubitemid27105536)
32. Kieback D. G., McCamant S. K, Press M. F. el at. Improved prediction of survival in advanced adenocarcinoma of the ovary by immunocytochemical analysis and the composition adjusted receptor level of the estrogen receptor. Cancer Res 1993; 53: 21: 5188-5192.
33. Rose P. G., Reale F. R., Longcope C., Hunter R. E. Prognostic significance of estrogen and progesterone receptors in epithelial ovarian cancer. Obstet Gynecol 1990; 76: 2: 258-263.
34. Masood S., Heitmann J., Nuss R. C., Benrubi G. I. Clinical correlation of hormone receptor status in epithelial ovarian cancer. Gynecol Oncol 1989; 34: 1: 57-60.
35. Andert P., Fuith L. C., Daxenbichler G. et al. Correlation between steroid hormone receptors, histological and clinical parameters in ovarian carcinoma. Gynecol Obstet Invest 1988; 25:2:135-140.
36. Nardelli G. B., Lamaina V., Dal Pozzo M., Onnis G. L. Determination of ER in ovarian cancer using monoclonal antibody technology. Clin Exp Obstet Gynecol 1987; 14:3-4:185-187.
37. Sutton G. P., Senior M. B., Strauss J. F., Mikuta J. J. Estrogen and progesterone receptors in epithelial ovarian malignancies. Gynecol Oncol 1986; 23: 2: 176-182.
38. al- Timiml A., Buckley C. H., Fox H. An immunohistochemical study of the incidence and significance of sex steroid hormone binding sites in normal and neoplastic human ovarian tissue. Int J Gynecol Pathol 1985; 4: 1: 24-41.
39. Teufel G., Geyer H., de Gregorio G. et al. Estrogen and progesterone receptors in malignant ovarian neoplasms. Geburtshilfe Frauenheiikd 1983; 43: 12: 732-740.
40. Willcocks D., Toppila M., Hudson C. N. et al. Estrogen and progesterone receptors in human ovarian tumors. Gynecol Oncol 1983; 16: 2: 246-253.
41. BizziA., Codegoni A. M., Landoni F. et al. Steroid receptors in epithelial ovarian carcinoma: relation to clinical parameters and survival. Cancer Res 1988; 48: 21: 6222-6226.
42. Vang R., Gown A. M., Barry T. S. et al. Immunohistochemistry for estrogen and progesterone receptors in the distinction of primary and metastatic mucinous tumors in the ovary: an analysis of 124 cases. Mod Pathol 2006; 19: 1: 97-105. (Pubitemid 43250984)
43. Shiohara S., Shiozawa T., Shimizu M. et al. Histochemical analysis of estrogen and progesterone receptors and gastric-type mucin in mucinous ovarian tumors with reference to their pathogenesis. Cancer 1997; 80: 5: 908-916. (Pubitemid 27360473)
44. Ford L. C., Berek J. S., Lagasse L. D. et al. Estrogen and progesterone receptors in ovarian neoplasms. Gynecol Oncol 1983; 15: 3: 299-304.
45. Hegdall E. V., Christensen L., Hegdall C. K. et al. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study. Oncol Rep 2007; 18: 5: 1051-1059.
46. Lindgren P. R., Cajander S., Bäckström T. et al. Estrogen and progesterone receptors in ovarian epithelial tumors. Mol Cell Endocrinol 2004; 221: 1-2: 97-104.
47. Chan K. K, Wei N., Liu S. S. et al. Estrogen receptor subtypes in ovarian caneen a clinical correlation. Obstet Gynecol 2008; 111: 1: 144-151.
48. Fujimoto J., Hirose R., Sakaguchi H., Tamaya T. Clinical significance of expression of estrogen receptor alpha and beta mRNAs in ovarian cancers. Oncology 2000; 58: 4: 334-341.
49. Chu S., Mamen P., Burger H. G., Fuller P. J. Estrogen receptor isoform gene expression in ovarian stromal and epithelial tumors. J Clin Endocrinol Metab 2000; 85: 3: 1200-1205. (Pubitemid 32269372)
50. Chu S., Nishl Y., Yanase T. et al. Transrepression of estrogen receptor beta signalling by nuclear factor-kappab in ovarian granulosa cells. Mol. Endocrinol 2004; 18: 8: 1919-1928. (Pubitemid 39006499)
51. Farmola M. A., Gown A. M., Judson K. et al. Estrogen receptor alpha and progesterone receptor expression in ovarian adult granulosa cell tumors and Sertoli-Leydig cell tumors. Int J Gynecol Pathol 2007; 26: 4: 375-382. (Pubitemid 47476321)
52. Ito T., Tachibana M., Yamamoto S. et al. Expression of estrogen receptor (ER-alpha and ER-beta) mRNA in human prostate cancer. Eur Urol 2001; 40: 5: 557-563.
53. Yang G. S., Wang Y., Wang P., Chen Z. D. Expression of oestrogen receptor-alpha and oestrogen receptor-beta in prostate cancer. Chin Med J 2007; 120: 18: 1611-1615.
54. Yang G. S., Chen Z. D. Comparative studies of the expression of estrogen receptor-alpha and estrogen receptor-beta in prostatic carcinoma. Zhonghua Wai Ke Za Zhi 2004; 42: 18: 1111-1115.
55. LeavI.,LauK.M.,AdamsJ.Y.etal. Comparativestudiesoftheestrogenreceptorsbetaandalphaandtheandrogenreceptorinnor malhumanprostateglands,dysplasia,andinprimaryandmetastaticcarcinoma. AmJPathol2001;159:1:79-92.(Pubitemid33704195)
56. Horvath L. G., Henshall S. M., Lee C. S. et al. Frequent loss of estrogen receptor-beta expression in prostate cancer. Cancer Res 2001; 61: 14: 5331-5335.
57. Royuela M., de Miguel M. P., Bethencourt F. R. et al. Estrogen receptors alpha and beta in the normal, hyperplastic and carcinomatous human prostate. J Endocrinol 2001; 168: 3: 447-454. (Pubitemid 32241889)
58. Pasquali D., Staibano S., Prezfoso D. et al. Estrogen receptor beta expression in human prostate tissue. Mol Cell Endocrinol 2001; 178: 1-2: 47-50. (Pubitemid 32515349)
59. Linja M. J., Savinainen K. J., Tammela T. L. et al. Expression of ERalpha and ERbeta in prostate cancer. Prostate 2003; 55: 3: 180-186. (Pubitemid 36532396)
60. Fixemer T., Remberger K., Bonkhoff H. Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma. Prostate 2003; 54: 2: 79-87. (Pubitemid 36120323)
61. Lai J. S., Brown L. G., True L. D. et al. Metastases of prostate cancer express estrogen receptor-beta. Urology 2004; 64: 4: 814-820. (Pubitemid 39446081)
62. Fujimoto M., Yoshino E., Hirakawa K. et al. Estrogen receptors in brain tumors. Clin Neuropharmacol 1984; 7: 4: 357-362.
63. Berny W., Weiser A., Jarmundowicz W. et al. Analysis of expression of estrogen (ER) and progesterone receptors (PR) in brain glial tumors and its correlation with expression of p53 protein and proliferating cell nuclear antigen (PCNA). Neurol Neurochir Pol 2004; 38: 5: 367-371.
64. PoissonM.,PertulsetB.F.,HauwJ.J.etal. Steroidhormonereceptorsinhumanmeningiomas,gliomasandbrainmetastases. JNeurooncol1983;1:3:179-189.(Pubitemid14201390)
65. Hilbig A., Barbosa-Coutinho L. M. Meningiomas and hormonal receptors. Immunohistochemical study in typical and non-typical tumors. Arq Neuropsiquiatr 1998; 56: 2: 193-199.
66. KostronH.,DaxenbichlerG.,MalerH. Steroidreceptorsandatypicalhistologyasprognosticparametersinmeningioma.WienKlin. Wochenschr1990;102:18:525-528.(Pubitemid20328111)
67. Kornblum J. A., Bay J. W., Gupta M. K. Steroid receptors in human brain and spinal cord tumors. Neurosurgery 1988; 23: 2: 185-188.
68. WhittleI.R.,HawkinsR.A.,MillerJ.D. Sexhormonereceptorsinintracranialtumoursandnormalbrain.EurJSurgOncol1987;13:4: 303-307.(Pubitemid17130181)
69. MorescoR.M,ScheithauerB.W.,LucignaniG.etal. Oestrogenreceptorsinmeningiomas:acorrelativePETandimmunohistochemicalstudy. NuclMedCommun1997;18:7:606-615.(Pubitemid27333224)
70. Maluri F., Montagnani S., Gallicchio B. Estrogen and progesterone receptors in meningiomas. Surg Neurol 1986; 26: 5: 435-440.
71. Yu Z. Y., Wrange O., Haglund B. et al. Estrogen and progestin receptors in intracranial meningiomas. J Steroid Biochem 1982; 16: 3: 451-456. (Pubitemid 12080122)
72. OmuleckaA.,PapierzW.,Nawrocka-KuneckaA.,Lewy-TrendaI. Immunohistochemicalexpressionofprogesteroneandestrogenreceptorsinmeningiomas. FoliaNeuropathol2006;44:2:111-115.(Pubitemid44083241)
73. Carroll R. S., Zhang J., Black P. M. Expression of estrogen receptors alpha and beta in human meningiomas. J Neurooncol 1999; 42: 2: 109-116.
74. LeeL.S.,ChiC.W.,ChangT.J.etal. SteroidhormonereceptorsinmeningiomasofChinesepatients.Neurosurgery1989;25:4: 541-545.(Pubitemid19236258)
75. Brentanl M. M., Lopes M. T., Martins V. R., Plese J. P. Steroid receptors in intracranial tumors. Clin. Neuropharmacol. 1984; 7: 4: 347-350.
76. Donnell M. S, Meyer G. A, Donegan W. L. Estrogen-receptor protein in intracranial meningiomas. J Neurosurg 1979; 50: 4: 499-502.
77. Fujimoto M., Yoshino E., Ueda S. et al. Estrogen receptors in meningiomas and neurinomas. No To Shinkei 1982; 34: 4: 399-404.
78. Belcher S. M., Ma X., Le H. H. Blockade of estrogen receptor signalling inhibits growth and migration of medulloblastoma. Endocrinology 2009; 150: 3: 1112-1121.
79. Burdman J. A., Pauni M., Heredia Sereno G. M., Bordón A. E. Estrogen receptors in human pituitary tumors. Horm Metab Res 2008; 40: 8: 524-527.
80. Talan-Hranilović J., Gnjidit Z., Sajko T. et al. Comparative immunohistochemical analysis of estrogen receptor and chromogranin-A reactivity in plurihormonal human prolactinomas. Acta Med Croatica 2000; 54: 2: 59-63.
81. Kaptain G. J., Simmons N. E., Alden T. D. et al. Estrogen receptors in prolactinomas: a clinico-pathological study. Pituitary 1999; 1: 2: 91-98.
82. Chaidamn S. S., Swearingen B., Alexander J. M. Differential expression of estrogen receptor-beta (ER beta) in human pituitary tumors: functional interactions with ER alpha and a tumor-specific splice variant. J Clin Endocrinol Metab 1998; 83: 9: 3308-3315. (Pubitemid 28500977)
83. Sanno N., Teramoto A., Matsuno A. et al. Expression of Pit-1 and estrogen receptor messenger RNA in prolactin-producing pituitary adenomas. Mod Pathol 1996; 9: 5: 526-533.
84. SakaoH.,KogaM.,AraoM.etal.Enzyme- immunoassayforestrogenreceptorsinhumanpituitaryadenomas.ActaEndocrinol(Copenh.) 1989;120:2:233-238.(Pubitemid19049764)
85. Gittoes N. J., McCabe C. J., Sheppard M. C, Franktyn J. A. Estrogen receptor beta mRNA expression in normal and adenomatous pituitaries. Pituitary 1999; 1: 2: 99-104.
86. Pereira-Lima J. F., Marroni C. P., Pizarro C. B. et al. Immunohistochemical detection of estrogen receptor alpha in pituitary adenomas and its correlation with cellular replication. Neuroendocrinology 2004; 79: 3: 119-124.
87. Thapar K, Stefaneanu L., Kovacs K. et al. Estrogen receptor gene expression in craniopharyngiomas: an in situ hybridization study. Neurosurgery 1994; 35: 6: 1012-1017.
88. Yonemori K, Tsuta K, Shimizu C. et al. Immunohistochemical profiles of brain metastases from breast cancer. Neurooncol 2008; 90: 2: 223-228.
89. Sanna G., Franceschelli L., Rotmensz N. et al. Brain metastases in patients with advanced breast cancer. Anticancer Res 2007; 27: 4C: 2865-2869.
90. Zhou Z. W., Wan D. S., Wang G. Q. et al. Expression of estrogen receptor and progesterone receptor in colorectal caneen a quantitative study. Ai Zheng 2004; 23: 7: 851-854.
91. RaigosoP.,SanzL.,VizosoF.etal. Estrogenandprogesteronereceptorsincolorectalcancerandsurroundingmucosa. IntJBiolMarkers2001;16:4:262-267.(Pubitemid34168386)
92. Oshima C. T, Wonrahl D. R., Catarino R. M. et al. Estrogen and progesterone receptors in gastric and colorectal cancer. Hepatogastroenterology 1999; 46: 30: 3155-3158.
93. Kaklamanos I. G., Bathe O. F., Franceschi D. et al. Expression of receptors for estrogen and progesterone in malignant colonic mucosa as a prognostic factor for patient survival. J Surg Oncol 1999; 72: 4: 225-229. (Pubitemid 30007792)
94. Waliszewski P., Blaszczyk M., Wolinska- Witort E. et al. Molecular study of sex steroid receptor gene expression in human colon and colorectal carcinomas. J Surg Oncol 1997; 64: 1: 3-11. (Pubitemid 27082000)
95. Di Leo A., Messa C., Russo F. et al. Prognostic value of cytosolic estrogen receptors in human colorectal carcinoma and surrounding mucosa. Preliminary results. Dig Dis Sci 1994; 39: 9: 2038-2042. (Pubitemid 24306091)
96. Brentani M. M., Liberato M. H., Macedo T. M. et al. Steroid receptors in Brazilian patients with large bowel cancer. Braz J Med Biol Res 1993; 26: 3: 277-284.
97. Meggouh F., Lolntier P., Pezet D., Saez S. Status of sex steroid hormone receptors in large bowel cancer. Cancer 1991; 67: 7: 1964-1970.
98. Magnusson I., Rosen A. V., Nilsson R. et al. Receptors for epidermal growth factor and sex steroid hormones in human colorectal carcinomas. Anticancer Res 1989; 9: 2: 299-301.
99. Bracali G., Caracino A. M., Rossodivita F. et al. Estrogen and progesterone receptors in human colorectal tumour cells (study of 70 cases). Int J Biol Markers 1988; 3: 1: 41-48.
100. Marugo M., Molinari F., Fazzuoli L. et al. Estradiol and progesterone receptors in normal and pathologic colonic mucosa in humans. J. Endocrinol Invest 1985; 8: 2: 117-119.
101. Sica V., Contieri E., Nola E. et al. Estrogen and progesterone binding proteins in human colorectal cancer. A preliminary characterization of estradiol receptor. Tumori 1981; 67: 4: 307-314.
102. Alford T. C., Do H. M., Geelhoed G. W. et al. Steroid hormone receptors in human colon cancers. Cancer 1979; 43: 3: 980-984.
103. Berta L., Fronticelli Baldelli C., Fazzari A. et al. Sex Steroid receptors, secondary bile acids and colorectal cancer. A possible mechanism of interaction. Panminerva Med 2003; 45: 4: 261-266.
104. 104.SinghS.,SheppardM.C.,LongmanM.J. Sexdifferencesintheincidenceofcolorectalcaneenanexplorationofoestrogenandproges teronereceptors.Gut1993;34:5:611-615.(Pubitemid23146883)
105. Campbell-Thompson M., Lynch I. J., Bhardwaj B. Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer. Cancer Res 2001; 61: 2: 632-640.
106. Foley E. F., JazaeriA. A., Shupnik M. A. et al. Selective loss of estrogen receptor beta in malignant human colon. Ibid Cancer Res 2000; 60: 2: 245-248.
107. Qiu Y., Waters C. E., Lewis A. E. et al. Oestrogen-induced apoptosis in colonocytes expressing oestrogen receptor beta. J Endocrinol 2002; 174: 3: 369-377.
108. Jassam N., Bell S. M., Speirs V., Quirke P. Loss of expression of oestrogen receptor beta in colon cancer and its association with Dukes' staging. Oncol Rep 2005; 14: 1: 17-21.
109. XieL.Q.,YuJ.P.,LuoH.S. Expressionofestrogenreceptorbetainhumancolorectalcancer.WorldJGastroenterol2004; 10:2:214-217.(Pubitemid38195264)
110. Witte D., Chirala M., Younes A. et al. Estrogen receptor beta is expressed in human colorectal adenocarcinoma. Hum Pathol 2001; 32: 9: 940-944. (Pubitemid 32911316)
111. Castiglione F., Taddei A., Degl'Innocenti D. R. et al. Expression of estrogen receptor beta in colon cancer progression. Diagn Mol Pathol 2008; 17: 4: 231-236.
112. Nüssler N. C., Reinbacher K., Shanny N. et al. Sex-specific differences in the expression levels of estrogen receptor subtypes in colorectal cancer. Gend Med 2008; 5: 3: 209-217.
113. Konstantinopoulos P. A., Kominea A., Vandoros G. et al. Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation. Eur J Cancer 2003; 39: 9: 1251-1258. (Pubitemid 36579196)
114. Cavallini A., Messa C., Pricci M. et al. Distribution of estrogen receptor subtypes, expression of their variant forms, and clinicopathological characteristics of human colorectal cancer. Dig Dis Sci 2002; 47: 12: 2720-2728. (Pubitemid 35471613)
115. Hershberger P.A., Stabile L. P., Kanterewicz B. et al. Estrogen receptor beta (ERbeta) subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-smaU cell lung cancer cells. J Steroid Biochem Mol Biol 2009; 116: 1-2: 102-109.
116. Hershberger P. A., Vasquez A. C. Kanterewicz B. et al. Regulation of endogenous gene expression in human non-small cell lung cancer cells by estrogen receptor ligands. Cancer Res 2005; 65: 4: 1598-1605. (Pubitemid 40270190)
117. Hammoud Z., Tan B., Badve S., Bigsby R. M. Estrogen promotes tumor progression in a genetically defined mouse model of lung adenocarcinoma. Endocr Relat Cancer 2008; 15: 2: 475-483.
118. Morch L. S., Lokkegaard E., Andreasen A. H. et al. Hormone therapy and ovarian cancer. JAMA 2009; 302: 3: 298-305.
119. Mollerup S., Jorgensen K, Berge G., Haugen A. Expression of estrogen receptors alpha and beta in human lung tissue and cell lines. Lung Cancer 2002; 37: 2: 153-159.
120. BarkhemT.,CarlssonB.,NilssonY.etal. Differentialresponseofestrogenreceptoralphaandestrogenreceptorbeta- partialestrogenagonists/antagonists.Mol.Pharmacol1998;54:1:105-112. (Pubitemid28337592)
121. KawaiH.,IshiiA.,WashiyaK.etal. CombinedoverexpressionofEGFRandestrogenreceptoralphacorrelateswithapooroutcomei nlungcancer.AnticancerRes2005;25:6C:4693-4698.(Pubitemid41729532)